Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meshkov

Showing results (331-340 of 408) with videos related to

Pageof 41
Sort By:
Frontiers in Cardiovascular Medicine|June 18, 2026
Personalized polygenic profiling based on the genetic architecture of lipid metabolism in the Russian populationAleksandra Mamchur, Maria Bruttan, Veronika Daniel, et al.
Frontiers in Cardiovascular Medicine|June 21, 2023
Genetic landscape in Russian patients with familial left ventricular noncompactionAlexey N Meshkov, Roman P Myasnikov, Anna V Kiseleva, et al.
Terapevticheskii Arkhiv|October 28, 2024
[A clinical case of reverse left ventricular remodeling in patient with pathogenic TTN mutation. Case report]S N Nasonova, A N Meshkov, I V Zhirov, et al.
Plos One|December 29, 2017
Policies for biosimilar uptake in Europe: An overviewEvelien Moorkens, Arnold G Vulto, Isabelle Huys, et al.
Gene|October 29, 2025
Cardiomyopathies, heart rhythm and conduction disorders as phenotypic manifestation of genetic variants in large cohort of cardiac patients: results of whole-genome studyElena M Rimskaya, Svetlana N Nasonova, Alexey N Meshkov, et al.
Frontiers in Genetics|September 10, 2025
Prevalence and penetrance of pathogenic and likely pathogenic <i>LDLR</i> and <i>APOB</i> gene variants linked to familial hypercholesterolemia and increased risk of ischemic heart diseaseI K Dzhumaniiazova, A N Meshkov, V V Daniel, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 31, 2019
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTAPatricia Vella Bonanno, Anna Bucsics, Steven Simoens, et al.
Biomedicines|November 11, 2022
Diversities in the Gut Microbial Patterns in Patients with Atherosclerotic Cardiovascular Diseases and Certain Heart Failure PhenotypesOxana M Drapkina, German A Ashniev, Olga A Zlobovskaya, et al.
Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.
Frontiers in Public Health|December 21, 2018
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited BudgetsBrian Godman, Anna Bucsics, Patricia Vella Bonanno, et al.
Pageof 41

Showing results (331-340 of 408) with videos related to

Sort By:
Pageof 41
Frontiers in Cardiovascular Medicine|June 18, 2026
Personalized polygenic profiling based on the genetic architecture of lipid metabolism in the Russian populationAleksandra Mamchur, Maria Bruttan, Veronika Daniel, et al.
Frontiers in Cardiovascular Medicine|June 21, 2023
Genetic landscape in Russian patients with familial left ventricular noncompactionAlexey N Meshkov, Roman P Myasnikov, Anna V Kiseleva, et al.
Terapevticheskii Arkhiv|October 28, 2024
[A clinical case of reverse left ventricular remodeling in patient with pathogenic TTN mutation. Case report]S N Nasonova, A N Meshkov, I V Zhirov, et al.
Plos One|December 29, 2017
Policies for biosimilar uptake in Europe: An overviewEvelien Moorkens, Arnold G Vulto, Isabelle Huys, et al.
Gene|October 29, 2025
Cardiomyopathies, heart rhythm and conduction disorders as phenotypic manifestation of genetic variants in large cohort of cardiac patients: results of whole-genome studyElena M Rimskaya, Svetlana N Nasonova, Alexey N Meshkov, et al.
Frontiers in Genetics|September 10, 2025
Prevalence and penetrance of pathogenic and likely pathogenic <i>LDLR</i> and <i>APOB</i> gene variants linked to familial hypercholesterolemia and increased risk of ischemic heart diseaseI K Dzhumaniiazova, A N Meshkov, V V Daniel, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 31, 2019
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTAPatricia Vella Bonanno, Anna Bucsics, Steven Simoens, et al.
Biomedicines|November 11, 2022
Diversities in the Gut Microbial Patterns in Patients with Atherosclerotic Cardiovascular Diseases and Certain Heart Failure PhenotypesOxana M Drapkina, German A Ashniev, Olga A Zlobovskaya, et al.
Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.
Frontiers in Public Health|December 21, 2018
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited BudgetsBrian Godman, Anna Bucsics, Patricia Vella Bonanno, et al.
Pageof 41